NAN:ASX
Nanosonics Ltd.
A$2.85
arrow_upward
+0.35%(+0.0100) 1D
Oct 12, 4:10:20 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NAN...
Open
A$2.85
High
A$2.89
Low
A$2.84
Mkt. cap
852.63M
Avg. vol.
1.12M
Volume
796.88K
P/E ratio
49.36
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
Open
A$2.85
High
A$2.89
Low
A$2.84
Mkt. cap
852.63M
Avg. vol.
1.12M
Volume
796.88K
P/E ratio
49.36
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
News stories
From web sources and news partners
FX News Group
·
52 minutes ago
HKEX introduces S&P 500 & HKEX Tech 100 Index in collaboration with S&P Dow Jones Indices
inkl
·
46 minutes ago
S&P 500 Profits Set to Surge More Than 30% in Q3 With AI Giants Dominating Growth
marketscreener.com
·
55 minutes ago
Goldman Sachs Adjusts Price Target on Dow to $31 From $33
Profile
Nanosonics is an ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people.
The company's Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
About Nanosonics Ltd.
CEOMichael Kavanagh
Employees508
Founded2001
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitenanosonics.com.au